Noom Med semaglutide: November 2026 price and position
As of November 20, 2026, Noom Med charges $249 per 28-day cycle for compounded semaglutide month to month, all-in, according to its own page. Over a year at that price you would pay $3,237 (13 four-week cycles).
Released · Last reviewed · how we verify
Noom Med semaglutide prices, read November 20, 2026
| Measure | Amount | Basis |
|---|---|---|
| Month to month, all-in | $249 | per 28-day cycle |
| Lowest printed rate | $249 | per 4 weeks, billed every 12 weeks |
| 3 cycles (84 days) at the month-to-month price | $747 | 3 four-week charges |
| 6 cycles (168 days) at the month-to-month price | $1,494 | 6 four-week charges |
| 13 cycles (364 days) at the month-to-month price | $3,237 | 13 four-week charges |
Where Noom Med sits
Among the 11 compounded programs in this dataset that print a month-to-month semaglutide price that applies at every dose or at the maintenance dose, the median is $149 and the range runs from $75.58 (Collective) to $299 (Remedy Meds). Price check: 7 of them cost less over a year at their month-to-month price, among them Collective ($75.58 a month), Mondae ($87 a month), Yucca Health ($89 a month), Eden ($99 a month). Programs whose page shows only a starting-dose or coupon price are left out of this comparison, because their maintenance-dose month cannot be confirmed.
Limitations and what to check before you enroll
Compounded semaglutide is not FDA-approved and is not the same product as Wegovy; it is made for an individual patient by a state-licensed pharmacy. Ask Noom Med for the all-in price at the maintenance dose, what is charged today and how often, and which pharmacy fills the prescription. A clinician decides whether any GLP-1 is right for you.
Frequently asked
How much does Noom Med charge for semaglutide?
As of November 20, 2026, Noom Med charges $249 per 28-day cycle for compounded semaglutide month to month, all-in, according to its own page. Over a year at that price you would pay $3,237 (13 four-week cycles).
Is Noom Med’s semaglutide FDA-approved?
No. Compounded semaglutide from any telehealth program, Noom Med included, is not FDA-approved and is not the same product as Wegovy or Ozempic. It is made for an individual patient by a state-licensed compounding pharmacy. Brand Wegovy is the FDA-approved version.
Where do these Noom Med figures come from?
From Noom Med’s own page (first-party read, changed, November 20, 2026), converted to an all-in month-to-month figure (medication plus any required recurring fee, before tax). The source link and read date are listed below, and the same figures are in the open dataset.
Sources
- FDA: Concerns with unapproved GLP-1 drugs used for weight loss (content current as of October 1, 2026; read November 20, 2026)
- Federal Register 91 FR 23431: proposed 503B bulks-list decision for semaglutide, tirzepatide and liraglutide (May 1, 2026; no final notice found as of November 20, 2026)
- Zepbound (tirzepatide) prescribing information on DailyMed (read November 20, 2026)
- Wegovy (semaglutide) prescribing information on DailyMed (read November 20, 2026)
- Noom Med pricing page (read November 20, 2026)